The role of oxidative stress in streptozotocin-induced diabetic nephropathy in rats

Archives of Endocrinology and Metabolism

Volumn 60, Issue 5, 2016, Pages 443-449

  Fernandes, Sheila Marques ^a   Cordeiro, Priscilla Mendes ^a,b   Watanabe, Mirian ^a   da Fonseca, Cassiane Dezoti ^a   Vattimo, Maria de Fatima Fernandes ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF AMAZONAS   (Brazil)

Author keywords

Diabetic nephropathy; Oxidative stress; Rats; Uninephrectomy

Indexed keywords

CREATININE; GLUCOSE BLOOD LEVEL; PEROXIDE; REACTIVE OXYGEN METABOLITE; STREPTOZOCIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL DERIVATIVE;

ALBUMINURIA; ANALYSIS; ANIMAL; BODY WEIGHT; CHEMICALLY INDUCED; DIABETIC NEPHROPATHY; DISEASE MODEL; EXPERIMENTAL DIABETES MELLITUS; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; KIDNEY; LIPID PEROXIDATION; MALE; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME FACTOR; URINE; WISTAR RAT;

ALBUMINURIA; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; GLOMERULAR FILTRATION RATE; KIDNEY; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PEROXIDES; RATS, WISTAR; REACTIVE OXYGEN SPECIES; STREPTOZOCIN; SULFHYDRYL COMPOUNDS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TIME FACTORS;

EID: 84993966993     PISSN: 23593997     EISSN: 23594292     Source Type: Journal    
DOI: 10.1590/2359-3997000000188     Document Type: Article

References (29)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-53.
2. Sheetz MJ, King GL. Molecular understanding of hyperglycemia’s adverse effects for diabetic complications. JAMA. 2002;288 (20):2579-88.
3. Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93(1):137-88.
4. Gonzales Suarez ML, Thomas DB, Barisoni L, Fornoni A. Diabetic nephropathy: Is it time yet for routine kidney biopsy? World J Diabetes. 2013;4(6):245-55.
5. Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes. 2008;57(6):1446-54.
6. Nath KA, Norby SM. Reactive oxygen species and acute renal failure. Am J Med. 2000;109(8):665-78.
7. Vallon V, Thomson SC. Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney. Annu Rev Physiol. 2012;74:351-75.
8. Dorea EL, Yu L, De Castro I, Campos SB, Ori M, Vaccari EM, et al. Nephrotoxicity of amphotericin B is attenueted by solubilizing with lipid emulsion. J Am Soc Nephrol. 1997;8(9):1415-22.
9. Dezoti Fonseca C, Watanabe M, Vattimo M de F. Role of heme oxygenase-1 in polymyxin B-induced nephrotoxicity in rats. Antimicrob Agents Chemother. 2012;56(10):5082-7.
10. Mancini G, Carbonara AO, Hermans JF. Imunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965;2(3):235-54.
11. Banerjee D, Madhusoodanan UK, Nayak S, Jacob J. Urinary hydrogen peroxide: a probably marker of oxidative stress in malignancy. Clin Chim Acta. 2003;334(1/2):205-9.
12. Gay C, Collins J, Gebicki JM. Hydrogen peroxide assay with the ferric-xylenol orange complex. Anal Biochem. 1999;273(2):149-55.
13. Shimizu MHM, Danilovic A, Andrade L, Volpi RA, Libório AB, Sanches TRC, et al. N-acetylcysteine protects against renal injury following bilateral ureteral obstruction. Nephrol Dial Transplant. 2008;10(23):3067-73.
14. Akerboom TPM, Sies H. Assay glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods Enzymol. 1981;77:373-82.
15. Watanabe M, de Moura Neiva LB, da Costa Santos CX, Martins Laurindo FR, Vattimo MFF. Isoflavone and the heme oxygenase system in ischemic acute kidney injury in rats. Food Chem Toxicol. 2007;45(12):2366-71.
16. Miyaji T, Kato A, Yasuda H, Fujigaki Y, Hishida A. Role of increase in p21 in cisplatin-induced acute renal failure in rats. J Am Soc Nephrol. 2001;12(5):900-8.
17. Badal SS, Danesh FR. New insights into molecular mechanisms of diabetic kidney disease. Am J Kidney Dis. 2014;63(suppl 2):S63-83.
18. Vallon V, Thomson SC. Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney. Annu Rev Physiol. 2012;74:351-75.
19. Lopes GS, Lemos CCS, Mandarim de Lacerda CA, Bregman R. Effect of unilateral nephrectomy on renal function of diabetic rats. Histol Histopathol. 2004;19(4):1085-8.
20. O’Bryan GT, Hostetter TH. The renal hemodynamic basis of diabetic nephropathy. Semin Nephrol. 1997;17(2):93-100.
21. Vallon V, Blantz RC, Thomson S. Glomerular hyperfiltration and salt paradox in early type 1 diabetes mellitus: a tubule-centric view. J Am Soc Nephrol. 2003;14(2):530-7.
22. Fineberg D, Jandeleit-Dahm KA, Cooper ME. Diabetic nephropathy: diagnosis and treatment. Nat Rev Endocrinol. 2013;9(12):713-23.
23. Sesso RCC, Lopes AA, Thomé FS, Lugon JR, Watanabe Y, Santos DR, et al. Diálise crônica no Brasil-Relatório do Censo Brasileiro de Diálise, 2011. J Bras Nefrol. 2012;34(3):272-7.
24. Jomova K, Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology. 2011;283(2-3):65-87.
25. Pingle SC, Mishra S, Marcuzzi A, Bhat SG, Sekino Y, Rybak LP, et al. Osmotic diuretics induce adenosine A1 receptor expression and protect renal proximal tubular epithelial cells against cisplatinmediated apoptosis. J Biol Chem. 2004;279(41):43157-67.
26. Heilig CW, Concepcion LA, Riser BL, Freytag SO, Zhu M, Cortes P. Overexpression of glucose transportes in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. J Clin Invest. 1995;96(4):1802-14.
27. Bhattacharya S, Manna P, Gachhui R, Sil PC. D-Saccharic acid 1,4-lactone protects diabetic rat kidney by ameliorating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via NF-κB and PKC signaling. Toxicol Appl Pharmacol. 2013;267(1):16-29.
28. Chen LH, Stead B, Advani SL, Yaqoob N, Thai K, Kabir MG, et al. Hyperglycemia and renal mass ablation synergistically augment albuminuria in the diabetic subtotally nephrectomized rat: implications for modeling diabetic nephropathy. Nephron Extra. 2012;2(1):115-24.
29. Sun H, Ge N, Shao M, Cheng X, Li Y, Li S, et al. Lumbrokinase attenuates diabetic nephropathy through regulating extracelular matrix degradation in streptozotocin-induced diabetic rats. Diabetes Res Clin Pract. 2013;100(1):85-95.